Today’s top gainers include the company Perrigo Company plc (NYSE:PRGO) which is in the industry Drug Related Products, gaining -0.12% today. In the last week its performance is -2.37%, and -23.69% for the past quarter. Currently, Perrigo Company plc, PRGO has a target price of 117.63, so today’s gain of -0.12% is a significant step towards its target price. The GAP today is therefore 0.14%.
Perrigo Company plc (NYSE:PRGO), has a market cap of 13108.05, and is based in Ireland. Insider ownership is at 0.20%, and institutional ownership is 79.20%.
At the current price of 92.35, it has a dividend yield of 0.63%, and its target price is 117.63. This is with a profit margin of -3.80%, and total debt/equity of 0.66. Perrigo Company plc (NYSE:PRGO) has a P/E of *TBA, as well as a forward P/E of 10.19.
With a current EPS of -1.91, and a forecasted EPS growth for next year at 10.52%,Perrigo Company plc (NYSE:PRGO) has had a EPS growth for the past five years at -59.80%. For the next five years EPS growth is projected to be 8.04%.
Performance for the year is -51.06%. Since its IPO date on 12/17/1991, the total performance to date is -35.93%.
Volume today for Perrigo Company plc (NYSE:PRGO), is 666079, while its average volume is 2994.58. Whilst the total gain today was -0.12%, it did have a day high of -16.80%.
Volatility for this week has been at 2.55%, and 2.63% for the month. The 52-week low for Perrigo Company plc, PRGO has been 9.00%, while the 52-week-high has reached -53.26%.
Looking at its return of investments, which is 0.80%, and its return on assets is -1.10%. Perrigo Company plc (NYSE:PRGO) has an operating margin of -0.40%. With a sales growth of 31.80% quarter over quarter. Bearing in mind that Perrigo Company plc, PRGO is in the sector Healthcare, its long-term debt/equity is 0.6, and has a current ratio of 1.4 and 1 for quick ratio.
So what is the value of Perrigo Company plc? Well its PEG is *TBA, and the P/S is 2.31, along with a P/B of 1.34. Meanwhile it has a p/cash of *TBA.